secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001193125-23-277877
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aligos Therapeutics President and Board member Leonid Beigelman resigns
-----------------------------------------------------------------------

- Leonid Beigelman resigned from the Board effective Nov 9, 2023.
- Beigelman also resigned as President effective Dec 1, 2023.
- Resignation is not related to any disagreement with the Company.
- No replacement for President has been announced.
- Beigelman's departure removes a key scientific leader from management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/0001193125-23-277877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523277877/d850603d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer